Actively Recruiting
Phage Safety Retrospective Cohort Study
Led by Hospices Civils de Lyon · Updated on 2023-04-13
25
Participants Needed
1
Research Sites
291 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.
CONDITIONS
Official Title
Phage Safety Retrospective Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients having had a bone, joint, or implant infection treated by phagotherapy
- Patients who experienced an adverse event following phagotherapy treatment
You will not qualify if you...
- None specified
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospices Civils de Lyon
Lyon, France, 69004
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here